Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Baumgarten

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
HIV Clinical Trials|March 21, 2019
Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-RegistryJenny Bischoff, Stefan Mauss, Christiane Cordes, et al.
BMC Infectious Diseases|October 13, 2024
A seroprevalence study indicates a high proportion of clinically undiagnosed MPXV infections in men who have sex with men in Berlin, GermanyUlrich Marcus, Janine Michel, Nikolay Lunchenkov, et al.
European Journal of Gastroenterology & Hepatology|April 10, 2019
Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infectionGerrit Post, Noga Shalev, Axel Baumgarten, et al.
British Journal of Haematology|June 24, 2017
Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantationTim Strüßmann, Kristina Fritsch, Axel Baumgarten, et al.
BMC Infectious Diseases|October 29, 2024
Correction: A seroprevalence study indicates a high proportion of clinically undiagnosed MPXV infections in men who have sex with men in Berlin, GermanyUlrich Marcus, Janine Michel, Nikolay Lunchenkov, et al.
Infectious Diseases and Therapy|June 24, 2026
Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C InfectionChristoph Boesecke, Kimberly Workowski, Stuart C Gordon, et al.
Journal of the International AIDS Society|November 15, 2014
144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohortEva Wolf, Andreas Trein, Axel Baumgarten, et al.
Journal of Viral Hepatitis|July 21, 2021
Late presentation of chronic hepatitis C patients in the era of direct-acting antivirals-Data from the German Hepatitis C-RegistryJenny Bischoff, Stefan Mauss, Thomas Lutz, et al.
European Journal of Medical Research|July 2, 2011
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the conceptM Obermeier, P Ingiliz, L Weitner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infectionMartin Vogel, Katja Deterding, Johannes Wiegand, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
HIV Clinical Trials|March 21, 2019
Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-RegistryJenny Bischoff, Stefan Mauss, Christiane Cordes, et al.
BMC Infectious Diseases|October 13, 2024
A seroprevalence study indicates a high proportion of clinically undiagnosed MPXV infections in men who have sex with men in Berlin, GermanyUlrich Marcus, Janine Michel, Nikolay Lunchenkov, et al.
European Journal of Gastroenterology & Hepatology|April 10, 2019
Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infectionGerrit Post, Noga Shalev, Axel Baumgarten, et al.
British Journal of Haematology|June 24, 2017
Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantationTim Strüßmann, Kristina Fritsch, Axel Baumgarten, et al.
BMC Infectious Diseases|October 29, 2024
Correction: A seroprevalence study indicates a high proportion of clinically undiagnosed MPXV infections in men who have sex with men in Berlin, GermanyUlrich Marcus, Janine Michel, Nikolay Lunchenkov, et al.
Infectious Diseases and Therapy|June 24, 2026
Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C InfectionChristoph Boesecke, Kimberly Workowski, Stuart C Gordon, et al.
Journal of the International AIDS Society|November 15, 2014
144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohortEva Wolf, Andreas Trein, Axel Baumgarten, et al.
Journal of Viral Hepatitis|July 21, 2021
Late presentation of chronic hepatitis C patients in the era of direct-acting antivirals-Data from the German Hepatitis C-RegistryJenny Bischoff, Stefan Mauss, Thomas Lutz, et al.
European Journal of Medical Research|July 2, 2011
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the conceptM Obermeier, P Ingiliz, L Weitner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infectionMartin Vogel, Katja Deterding, Johannes Wiegand, et al.
Pageof 6